BEAM
Price
$20.01
Change
+$0.13 (+0.65%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
2.01B
40 days until earnings call
LYEL
Price
$9.69
Change
+$0.26 (+2.76%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
143.49M
34 days until earnings call
Interact to see
Advertisement

BEAM vs LYEL

Header iconBEAM vs LYEL Comparison
Open Charts BEAM vs LYELBanner chart's image
Beam Therapeutics
Price$20.01
Change+$0.13 (+0.65%)
Volume$111.59K
Capitalization2.01B
Lyell Immunopharma
Price$9.69
Change+$0.26 (+2.76%)
Volume$5.58K
Capitalization143.49M
BEAM vs LYEL Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. LYEL commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and LYEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (BEAM: $20.01 vs. LYEL: $9.69)
Brand notoriety: BEAM and LYEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. LYEL: 22%
Market capitalization -- BEAM: $2.01B vs. LYEL: $143.49M
BEAM [@Biotechnology] is valued at $2.01B. LYEL’s [@Biotechnology] market capitalization is $143.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileLYEL’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • LYEL’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while LYEL’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • LYEL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than LYEL.

Price Growth

BEAM (@Biotechnology) experienced а +16.74% price change this week, while LYEL (@Biotechnology) price change was +6.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

LYEL is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.01B) has a higher market cap than LYEL($143M). BEAM YTD gains are higher at: -19.315 vs. LYEL (-24.297). LYEL has higher annual earnings (EBITDA): -204.02M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. LYEL (301M). LYEL has less debt than BEAM: LYEL (48.9M) vs BEAM (158M). BEAM has higher revenues than LYEL: BEAM (63.6M) vs LYEL (65K).
BEAMLYELBEAM / LYEL
Capitalization2.01B143M1,407%
EBITDA-399.03M-204.02M196%
Gain YTD-19.315-24.29779%
P/E RatioN/AN/A-
Revenue63.6M65K97,846%
Total Cash1.22B301M405%
Total Debt158M48.9M323%
TECHNICAL ANALYSIS
Technical Analysis
BEAMLYEL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ESEAX33.840.30
+0.89%
Eaton Vance Atlanta Capital Sel Eq A
VRTPX21.660.04
+0.19%
Vanguard Real Estate II Index
MXYKX5.40N/A
N/A
Empower T. Rowe Price Mid Cp Gr Instl
JSJIX16.28N/A
N/A
JHancock Small Cap Dynamic Growth I
WCMOX12.24N/A
N/A
WCM Focused International Opps Ins

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.65%
CRSP - BEAM
71%
Closely correlated
+0.97%
RXRX - BEAM
64%
Loosely correlated
+1.15%
NTLA - BEAM
64%
Loosely correlated
+0.09%
SYRE - BEAM
59%
Loosely correlated
+1.68%
ABSI - BEAM
58%
Loosely correlated
+2.97%
More

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+2.76%
VCYT - LYEL
46%
Loosely correlated
-0.25%
ZNTL - LYEL
42%
Loosely correlated
+1.61%
TYRA - LYEL
41%
Loosely correlated
-0.50%
CRBU - LYEL
40%
Loosely correlated
N/A
BEAM - LYEL
38%
Loosely correlated
+0.65%
More